Evidence map›Paper›PMID 36139985›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Antiprotozoal Activity of Thymoquinone (2-Isopropyl-5-methyl-1,4-benzoquinone) for the Treatment of

Kamal A Qureshi, Mahrukh Imtiaz, Ibrahim Al Nasr, Waleed S Koko, Tariq A Khan, Mariusz Jaremko, Syed Mahmood, M Qaiser Fatmi

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Medicinal Plants as Therapeutic Alternatives to CombatAntibiotics (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Kamal A QureshiDepartment of Pharmaceutics, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia.ORCID 0000-0002-3498-797X
Mahrukh ImtiazDepartment of Biosciences, COMSATS University Islamabad, Islamabad 45600, Pakistan.
Ibrahim Al NasrDepartment of Laboratory Sciences, College of Science and Arts, Qassim University, Ar Rass 51921, Saudi Arabia.ORCID 0000-0003-4690-1050
Waleed S KokoDepartment of Laboratory Sciences, College of Science and Arts, Qassim University, Ar Rass 51921, Saudi Arabia.
Tariq A KhanDepartment of Clinical Nutrition, College of Applied Health Sciences, Qassim University, Ar Rass 51921, Saudi Arabia.
Mariusz JaremkoSmart-Health Initiative (SHI) and Red Sea Research Center (RSRC), Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.
Syed MahmoodDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
M Qaiser FatmiDepartment of Biosciences, COMSATS University Islamabad, Islamabad 45600, Pakistan.
Qassim University · SACOMSATS University Islamabad · PKKing Abdullah University of Science and Technology · SAUniversity of Malaya · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis, a neglected tropical parasitic disease (NTPD), is caused by various

Indexed as

antileishmanial activitymolecular dockingmolecular dynamics simulationsqualene monooxygenasethymoquinone

Identifiers

PMID36139985
PMCPMC9495120
OpenAlexW4295063244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.